This year, about 191,930 men in the U.S. will be diagnosed with prostate cancer and about 33,330 will die from the disease. For more than a decade, researchers have debated whether men should have an annual prostate-specific antigen (PSA) blood test to screen for prostate cancer. In this episode of KP Research Radio, we talk about the potential risks and benefits of prostate cancer screening with Joseph Presti, MD, an adjunct researcher at the Kaiser Permanente Northern California Division of Research and the regional leader of Urologic Oncology Surgery for The Permanente Medical Group.
Who should be screened for prostate cancer?
